OMX Ventures

Venture Capital Chicago, United States ·Founded 2020

Overview

OMX Ventures is a venture capital firm focused on investing in a new era of bioengineering and its application for better tools, medicines, foods, industrial products, and more. We specialize in early…

Investment Focus

  • Focus on early-stage biotechnology companies
  • Alignment with OMX Ventures' investment strategy in bioengineering and related fields
  • Potential for scalability and impact in the biotech sector

Portfolio Companies

Delix TherapeuticsConstructive BioFreya BiosciencesMythic TherapeuticsMatterworksVedaBio

Reach OMX Ventures directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about OMX Ventures

What sectors does OMX Ventures invest in?

OMX Ventures invests in Healthcare, Artificial Intelligence, Life Sciences, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Chicago, United States. OMX Ventures is listed as a venture capital in the ConnectSafely investor database.

What stage does OMX Ventures invest at?

OMX Ventures backs companies at Seed and Series A.

Which regions does OMX Ventures invest in?

OMX Ventures invests across United States.

Who are the partners at OMX Ventures?

Team members listed for OMX Ventures include Swetha Murali (Vice President) and Syed Haider (Director, Site Orchestration, Team - Decentralized Clinical Trials (DCT)).

What companies has OMX Ventures invested in?

OMX Ventures's portfolio includes Delix Therapeutics, Constructive Bio, Freya Biosciences, Mythic Therapeutics, Matterworks and VedaBio.

How do I contact OMX Ventures?

OMX Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database